CU20220009A7 - Nuevas formulaciones de comprimido de fosfomicina - Google Patents

Nuevas formulaciones de comprimido de fosfomicina

Info

Publication number
CU20220009A7
CU20220009A7 CU2022000009A CU20220009A CU20220009A7 CU 20220009 A7 CU20220009 A7 CU 20220009A7 CU 2022000009 A CU2022000009 A CU 2022000009A CU 20220009 A CU20220009 A CU 20220009A CU 20220009 A7 CU20220009 A7 CU 20220009A7
Authority
CU
Cuba
Prior art keywords
tablet
fosfomicin
new formulations
fosfomycin trometamol
anhydrous
Prior art date
Application number
CU2022000009A
Other languages
English (en)
Inventor
Ollé Ramon Francesch
Ortega Marta Prior
Original Assignee
Labiana Health S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labiana Health S L filed Critical Labiana Health S L
Publication of CU20220009A7 publication Critical patent/CU20220009A7/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

<p>La presente invención se refiere a formulaciones de comprimido de fosfomicina trometamol y a métodos de fabricación de las mismas. Más específicamente, se refiere a una composición farmacéutica oral en forma de comprimido que comprende:</p> <p>a. fosfomicina trometamol;</p> <p>b. hidrogenofosfato de calcio anhidro; y</p> <p>c. celulosa microcristalina anhidra.</p> <p> </p>
CU2022000009A 2021-02-10 2022-02-04 Nuevas formulaciones de comprimido de fosfomicina CU20220009A7 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP21382104 2021-02-10

Publications (1)

Publication Number Publication Date
CU20220009A7 true CU20220009A7 (es) 2023-09-07

Family

ID=74732835

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2022000009A CU20220009A7 (es) 2021-02-10 2022-02-04 Nuevas formulaciones de comprimido de fosfomicina

Country Status (11)

Country Link
US (1) US11833250B2 (es)
EP (1) EP4043006B1 (es)
AR (1) AR124833A1 (es)
BR (1) BR102022002475A2 (es)
CA (1) CA3147662A1 (es)
CO (1) CO2022001244A1 (es)
CU (1) CU20220009A7 (es)
ES (1) ES2970581T3 (es)
MX (1) MX2022001746A (es)
PE (1) PE20221446A1 (es)
TW (1) TW202245740A (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20021725A1 (it) 2002-08-01 2002-10-31 Zambon Spa Composizioni farmaceutiche ad attivita' antibiotica.
ES2244333B1 (es) 2004-05-18 2006-08-01 Simbec Iberica, Sl Preparado farmaceutico oral de fosfomicina estable y apto para diabeticos.
TW201129386A (en) 2009-11-05 2011-09-01 Fmc Corp Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
ES2385158B1 (es) 2010-12-24 2013-05-28 Arafarma Group, S.A. Composición farmacéutica de fosfomicina
US8604078B2 (en) 2011-04-06 2013-12-10 Carlos Picornell Darder Fosfomycin pharmaceutical composition

Also Published As

Publication number Publication date
CA3147662A1 (en) 2022-08-10
BR102022002475A2 (pt) 2022-08-23
ES2970581T3 (es) 2024-05-29
EP4043006A1 (en) 2022-08-17
MX2022001746A (es) 2022-08-11
CO2022001244A1 (es) 2023-02-16
EP4043006B1 (en) 2023-12-06
AR124833A1 (es) 2023-05-10
EP4043006C0 (en) 2023-12-06
US11833250B2 (en) 2023-12-05
PE20221446A1 (es) 2022-09-21
TW202245740A (zh) 2022-12-01
US20220387329A1 (en) 2022-12-08

Similar Documents

Publication Publication Date Title
CY1123549T1 (el) Σταθερη φαρμακευτικη συνθεση και μεθοδοι χρησης αυτης
ECSP066376A (es) FORMA CRISTALINA GAMMA-d DEL CLORHIDRATO DE IVABRADINA, SU PROCEDIMIENTO DE PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LA CONTIENEN
ECSP066375A (es) Forma cristalina gamma de clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmacéuticas que la contienen
BR112012007412A2 (pt) tabletes transformáveis de forma oral.
ECSP066715A (es)
BR112012028291A2 (pt) composições farmacêuticas e métodos para sua produção
BRPI0908052A2 (pt) Composições farmacêuticas de entacapone, levodopa e carbidopa com biodisponibilidade melhorada
GT201000275A (es) Cápsula para la prevención de enfermedades cardiovasculares
EA201890193A1 (ru) Композиция для ухода за полостью рта
CY1122114T1 (el) Καταπινομενα δισκια ν-ακετυλοκυστεϊνης
UY39390A (es) Forma amorfa de un inhibidor de la malt1 y formulaciones del mismo
AR067140A2 (es) Nuevo procedimiento de tratamiento de frutas o legumbres mediante el ion fosforoso y las composiciones correspondientes
AR081742A1 (es) Envoltura de articulo para fumar de baja tendencia a la ignicion (lip) y aparato, metodo y articulo para fumar relacionados
EA201001108A1 (ru) Диспергируемые во рту таблетки, содержащие основание эсциталопрама, и способ их получения
EA201071183A1 (ru) Безводная кристаллическая форма малеата орвепитанта
CU20220009A7 (es) Nuevas formulaciones de comprimido de fosfomicina
EA200901591A1 (ru) Фармацевтические композиции производных s-алкилизотиоурония с маскированным вкусом
CL2008002828A1 (es) Tableta oral que comprende una cantidad mayor de 38% de alisquireno o una de sus sales y fosfato acido de calcio como relleno.
DE60303041D1 (de) Fosinopril-formulierung
ECSP13013043A (es) Composición oral líquida que comprende sodio divalproex y proceso para preparar la misma
ECSP11011138A (es) Formulaciones de desintegración rápida pre-compactadas de compuestos con baja biodisponibilidad oral
ECSP055997A (es) Vacuna de vibrio cholerae inactivada en tabletas
JOP20220211A1 (ar) تركيبات صيدلانية من أملاح إستر كولين حمض ليبويك وطرق للمعالجة باستخدامها
EA201591319A1 (ru) Фармацевтические композиции, содержащие декскетопрофен и трамадол
AR125190A1 (es) Formulación